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Celiac disease (CD) is an immunological disorder. Clinical manifestations occur as a result of intestinal mucosa damage and
malabsorption. CD is also associated with extraintestinal manifestations and autoimmune disorders. The coexistence of CD and
autoimmune diseases has been described before. In this article, a patient with CD presenting with thrombocytopenia is discussed.
1. Introduction
Celiac disease (CD) is an immunological disorder caused by
gluten intolerance. Short stature and chronic diarrhea are
the most common findings in CD [1, 2]. In addition to typ-
ical malabsorption symptoms, extraintestinal manifestations
like skin lesions, osteoporosis, elevated transaminases, and
hematological manifestations can be first findings of CD
[2, 3]. Also, CD can be associated with autoimmune disorders
[4]. In this article, a patient with CD presenting with throm-
bocytopenia is discussed.
2. Case
A 9-year-old girl was admitted to our pediatric hematology
unit with petechiae, ecchymoses, and history of a viral illness.
Physical examination revealed mild hepatomegaly, growth
failure, and common petechiae and ecchymoses. Cardiovas-
cular, pulmonary, and neurological examination were nor-
mal. There was no evidence of any preceding medication.
The initial investigations revealed awhite blood cell count
of 6360/mm3, hemoglobin of 11,4 gr/dl, and a platelet count
of 28.000/mm3. No blast and average of 1-2 large platelets
were seen in the blood smear. Further laboratory evaluation
showed a prothrombin time of 12.1 s, an INR of 1.1, a partial
thromboplastin time of 28 s, aspartate transaminase (AST)
of 174 IU/L, alanine transaminase (ALT) of 193 IU/L, lac-
tate dehydrogenase (LDH) of 914U/L, and an erythro-
cyte sedimentation rate of 14/h; urea (22mg/dL), creatinine
(0.3mg/dL), B12, and folic acid levels were normal. No evi-
dence of viral infections—including the hepatitis A virus, the
hepatitis B virus, the hepatitis C virus, the Epstein-Barr
virus, the Rubella virus, and Cytomegalovirus—was found.
Anti-nuclear antibody (ANA) was negative. Bone marrow
aspiration smear that showed increased mature and imma-
ture megakaryocytes was consistent with ITP.
Tissue transglutaminase (TG) and IgA endomysium-
specific antibodies (EMAs) were evaluated for the CD
because of the growth failure and elevated transaminase lev-
els. Tests showed positive values for CD. Therefore, an endo-
scopic biopsy was performed, and it was consistent with
total villous atrophy, increased number of intraepithelial
lymphocytes, and crypt hyperplasia in the intestinal mucosa
(Figures 1 and 2).
After a month starting a gluten-free diet, platelet count
increased to 87.000/mm3. Platelet count showed normal
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Table 1: Platelet count by months after gluten-free diet.
Month 1 2 3 4 5 7 9
Platelet count 87.000/mm3 95.000/mm3 112.000/mm3 137.000/mm3 183.000/mm3 168.000/mm3 199.000/mm3
Figure 1: Total villous atrophy, increased number of intraepithelial
lymphocytes, and crypt hyperplasia; CD3 ×400.
Figure 2: Total villous atrophy, increased number of intraepithelial
lymphocytes, and crypt hyperplasia; Hematoxylin & Eosin ×100.
values (183.000/mm3) in the fifth month of the diet (Table 1).
Any treatment for ITP was not given, such as immune
globulin and steroids.
3. Discussion
Clinical manifestations occur as a result of intestinal mucosa
damage and malabsorption in CD [5]. Iron deficiency is
the most common hematological disorder because of the
poor absorption of iron, and it is also one of the atypical
symptoms of CD [5, 6]. Folic acid and B12 deficiencies can
be seen, except regarding iron deficiencies [5]. In a study
of 22 patients with CD, iron deficiency anemia (IDA) was
detected in 21 patients, and also B12 deficiency was found in
7 of these patients. One patient had a folic acid deficiency
in addition to B12 and iron deficiencies [7]. Leukopenia and
thrombocytopenia can be also seen because of B12 and folic
acid deficiencies; however autoimmune cytopenias are some
of the clinical presentations of CD that develop with different
autoimmune mechanisms [6].
The first case report of the coexistence of ITP and CD in
a child was described in 1988 [8]. Numerous cooccurrences
of CD and ITP have been widely described in literature, and
it was showed that both diseases had similar autoimmune
mechanisms [9]. The innate immune system plays an impor-
tant role in the pathogenesis of CD, and Toll-like receptors
(TLRs) are key players in the innate immune system [10].
Zanoni et al. [11] reported that patients with CD have a
subset of transglutaminase antibodies that activate TLR4. In
addition, it is thought that the TLR4 expression in platelets
seems to be a prerequisite for thrombocytopenia [12].
Iron, ferritin, iron binding capacity, B12, and folic acid
levels were within normal limits in our patient.The diagnosis
of ITP was made because of the history of respiratory
tract infection, isolated thrombocytopenia, and increased
immature–mature megakaryocytes in the bone marrow. The
initial investigations for CD revealed positive values for TG
and EMAs, and intestinal biopsy showed total villous atrophy
associated with an increased number of intraepithelial lym-
phocytes and crypt hyperplasia in themucosa consistent with
a diagnosis of CD.
The literature described how a gluten-free diet could
improve ITP in a year without using corticosteroids or
immunoglobulin [13]. After the administration of a gluten-
free diet, the platelet count normalized in 5 months in our
patient. On the other hand, the coincidences of undiagnosed
CD with ITP are considered to be induced by viral infection,
and even the platelet count increased independently from
the gluten-free diet. However, our clinical experiences and
reports in the literature of association between the two con-
ditions suggest that diet plays an important role in treatment.
In conclusion, hematological abnormalities are frequently
present in CD. Also, ITP is one of the atypical presentations
of CD because of the similar autoimmune mechanisms. It is
important that CD treatment be considered in the differential
diagnosis of children who present with ITP.
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